| Nov 20 |
CVKD: Recent Financings Raise $9.8 Million…
|
| Nov 19 |
Cadrenal Therapeutics Named Anticoagulation Therapy Company of the Year by Pharma Tech Outlook
|
| Nov 14 |
Cadrenal Therapeutics files to sell 590,001 shares of common stock for holders
|
| Nov 12 |
CADRENAL THERAPEUTICS HIGHLIGHTS PRESENTATION AT EUROPEAN ASSOCIATION FOR CARDIO-THORACIC SURGERY (EACTS) MEDICAL CONGRESS
|
| Nov 8 |
Cadrenal Therapeutics reports Q3 results
|
| Nov 7 |
CADRENAL THERAPEUTICS PROVIDES THIRD-QUARTER CORPORATE UPDATE
|
| Nov 2 |
Cadrenal Therapeutics Announces Exercise of Warrants for $4.7 Million Gross Proceeds
|
| Oct 28 |
We're Keeping An Eye On Cadrenal Therapeutics' (NASDAQ:CVKD) Cash Burn Rate
|
| Oct 24 |
Cadrenal Therapeutics raises $5.1M via at-the-market facility
|
| Oct 24 |
Cadrenal Therapeutics Raises $5.1 Million via At-The-Market Facility
|
